Correlation Between Abcellera Biologics and 191216CY4

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and 191216CY4 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and 191216CY4 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and COCA COLA CO, you can compare the effects of market volatilities on Abcellera Biologics and 191216CY4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of 191216CY4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and 191216CY4.

Diversification Opportunities for Abcellera Biologics and 191216CY4

-0.23

Correlation Coefficient

Abcellera Biologics  191216CY4

Very good diversification

The 3 months correlation between Abcellera and 191216CY4 is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and COCA COLA CO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COCA A CO and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with 191216CY4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COCA A CO has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and 191216CY4 go up and down completely randomly.

Pair Corralation between Abcellera Biologics and 191216CY4

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the 191216CY4. In addition to that, Abcellera Biologics is 2.6 times more volatile than COCA COLA CO. It trades about -0.04 of its total potential returns per unit of risk. COCA COLA CO is currently generating about 0.13 per unit of volatility. If you would invest  5,922  in COCA COLA CO on December 26, 2024 and sell it today you would earn a total of  727.00  from holding COCA COLA CO or generate 12.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.0%
Values	Daily Returns

Abcellera Biologics  vs.  COCA COLA CO

Abcellera Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Abcellera Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

COCA A CO

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in COCA COLA CO are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 191216CY4 sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Abcellera Biologics and 191216CY4

The main advantage of trading using opposite Abcellera Biologics and 191216CY4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, 191216CY4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 191216CY4 will offset losses from the drop in 191216CY4's long position.

The idea behind Abcellera Biologics and COCA COLA CO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.